IDEXX Laboratories, Inc.
NASDAQIDEXX Laboratories enters its August 7 earnings report with options traders notably more defensive than they have been all year, even as the stock has quietly gained ground over the past month. The clearest tension in the data is in options positioning. The put/call ratio has jumped to 0.72, running more than two standard deviations above its 20-day average of 0.51 — the most…
Snapshot as of 16 Sept 2026
IDEXX Laboratories enters its August 7 earnings report with options traders notably more defensive than they have been all year, even as the stock has quietly gained ground over the past month. The clearest tension in…
IDEXX Laboratories heads into the back half of June with a quiet but persistent tension: short sellers are rebuilding positions even as the stock posts its best monthly gain in some time. The short interest story is…
IDEXX Laboratories heads into its May 5 Q1 earnings call with the stock under pressure, short interest at a one-month high, and analysts cutting targets — a convergence that raises the stakes on next week's print. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IDXX — free to start on ORTEX.
Sign up for free →Open IDXX on ORTEX